Showing results (31-40 of 145) with videos related to
Sort By:
Pageof 15
Biometrics|March 1, 1983
Assessment of diagnostic tests when disease verification is subject to selection biasC B Begg, R A GreenesBiometrics|September 1, 1988
Efficiency of balanced treatment allocation for survival analysisL A Kalish, D P HarringtonUrology|December 22, 1999
Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSAL A Kalish, J B McKinlayMedical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1984
Construction of receiver operating characteristic curves when disease verification is subject to selection biasR Gray, C B Begg, R A GreenesJournal of Chronic Diseases|January 1, 1986
The influence of uninterpretability on the assessment of diagnostic testsC B Begg, R A Greenes, B IglewiczCancer Clinical Trials|January 1, 1980
Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology GroupC B Begg, J L Cohen, J EllertonCancer Treatment Reports|July 1, 1981
Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancerR G Hahn, C B Begg, T DavisMedical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1984
Patient-oriented performance measures of diagnostic tests. 3. U-FactorK C Cain, R A Greenes, C B BeggThe New England Journal of Medicine|April 24, 1986
The use of ambulatory testing in prepaid and fee-for-service group practices. Relation to perceived profitabilityA M Epstein, C B Begg, B J McNeilBiometrics|September 1, 1996
Optimal sample size for a series of pilot trials of new agentsT J Yao, C B Begg, P O LivingstonPageof 15